Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruo-Yu Zhang

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
Small (Weinheim an Der Bergstrasse, Germany)|November 10, 2018
Quinic Acid-Conjugated Nanoparticles Enhance Drug Delivery to Solid Tumors via Interactions with Endothelial SelectinsJun Xu, Steve Seung-Young Lee, Howon Seo, et al.
Scientific Reports|June 5, 2015
Discovery and characterization of novel small-molecule inhibitors targeting nicotinamide phosphoribosyltransferaseTian-Ying Xu, Sai-Long Zhang, Guo-Qiang Dong, et al.
The Journal of Clinical Investigation|June 6, 2024
Off-target autophagy inhibition by SHP2 allosteric inhibitors contributes to their antitumor activity in RAS-driven cancersYiming Miao, Yunpeng Bai, Jinmin Miao, et al.
Journal of Medicinal Chemistry|July 9, 2014
Therapeutic potential of targeting the oncogenic SHP2 phosphataseLi-Fan Zeng, Ruo-Yu Zhang, Zhi-Hong Yu, et al.
ACS Medicinal Chemistry Letters|July 21, 2015
Exploring the Existing Drug Space for Novel pTyr Mimetic and SHP2 InhibitorsRongjun He, Zhi-Hong Yu, Ruo-Yu Zhang, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
Small (Weinheim an Der Bergstrasse, Germany)|November 10, 2018
Quinic Acid-Conjugated Nanoparticles Enhance Drug Delivery to Solid Tumors via Interactions with Endothelial SelectinsJun Xu, Steve Seung-Young Lee, Howon Seo, et al.
Scientific Reports|June 5, 2015
Discovery and characterization of novel small-molecule inhibitors targeting nicotinamide phosphoribosyltransferaseTian-Ying Xu, Sai-Long Zhang, Guo-Qiang Dong, et al.
The Journal of Clinical Investigation|June 6, 2024
Off-target autophagy inhibition by SHP2 allosteric inhibitors contributes to their antitumor activity in RAS-driven cancersYiming Miao, Yunpeng Bai, Jinmin Miao, et al.
Journal of Medicinal Chemistry|July 9, 2014
Therapeutic potential of targeting the oncogenic SHP2 phosphataseLi-Fan Zeng, Ruo-Yu Zhang, Zhi-Hong Yu, et al.
ACS Medicinal Chemistry Letters|July 21, 2015
Exploring the Existing Drug Space for Novel pTyr Mimetic and SHP2 InhibitorsRongjun He, Zhi-Hong Yu, Ruo-Yu Zhang, et al.
Pageof 4